ZISKA Pharma Tirzepatide Tizaro – 10mg / 12.5mg / 15mg (Prefilled Syringe)
Tizaro Tirzepatide by ZISKA Pharma is a pharmaceutical-grade dual GIP/GLP-1 receptor agonist, designed for individuals seeking powerful appetite suppression, enhanced satiety, and metabolic balance.
Tirzepatide targets two key metabolic pathways:
🔹 GLP-1 pathway
-
Supports appetite reduction
-
Promotes slower gastric emptying
-
Helps improve glucose control
🔹 GIP pathway
-
Enhances insulin sensitivity
-
Supports metabolic function
-
Enhances satiety and fullness
Because it activates both GIP and GLP-1 receptors simultaneously, Tirzepatide is recognized as more potent than single-pathway GLP-1 analogues like Semaglutide.
ZISKA Pharma’s Tizaro comes in a prefilled syringe format, ensuring clean dosing, convenience, and consistent pharmaceutical quality.
Available Strengths:
-
10mg – strong foundational support
-
12.5mg – intermediate/high potency
-
15mg – maximum-strength option for advanced use
Each dose is manufactured under strict pharmaceutical standards for purity, sterility, and reliability.
Key Benefits
- Dual-agonist (GIP + GLP-1) for superior appetite suppression
- Stronger metabolic impact compared to Semaglutide
- Helps reduce cravings and overeating
- Increases feelings of fullness after meals
- Supports improved metabolic balance
- Comes in convenient prefilled syringes
- ZISKA Pharma pharmaceutical-grade production
